199 related articles for article (PubMed ID: 31757784)
1. Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk.
Creed JH; Berglund AE; Rounbehler RJ; Awasthi S; Cleveland JL; Park JY; Yamoah K; Gerke TA
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):246-253. PubMed ID: 31757784
[TBL] [Abstract][Full Text] [Related]
2. Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.
Awasthi S; Berglund A; Abraham-Miranda J; Rounbehler RJ; Kensler K; Serna A; Vidal A; You S; Freeman MR; Davicioni E; Liu Y; Karnes RJ; Klein EA; Den RB; Trock BJ; Campbell JD; Einstein DJ; Gupta R; Balk S; Lal P; Park JY; Cleveland JL; Rebbeck TR; Freedland SJ; Yamoah K
Clin Cancer Res; 2021 Jan; 27(1):320-329. PubMed ID: 33037017
[TBL] [Abstract][Full Text] [Related]
3. Genes associated with prostate cancer are differentially expressed in African American and European American men.
Powell IJ; Dyson G; Land S; Ruterbusch J; Bock CH; Lenk S; Herawi M; Everson R; Giroux CN; Schwartz AG; Bollig-Fischer A
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):891-7. PubMed ID: 23515145
[TBL] [Abstract][Full Text] [Related]
4. Transcript analysis of commercial prostate cancer risk stratification panels in hard-to-predict grade group 2-4 prostate cancers.
Lehto TK; Stürenberg C; Malén A; Erickson AM; Koistinen H; Mills IG; Rannikko A; Mirtti T
Prostate; 2021 May; 81(7):368-376. PubMed ID: 33734461
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.
Rayford W; Beksac AT; Alger J; Alshalalfa M; Ahmed M; Khan I; Falagario UG; Liu Y; Davicioni E; Spratt DE; Schaeffer EM; Feng FY; Mahal B; Nguyen PL; Den RB; Greenberger MD; Bradley R; Watson JM; Beamer M; Stamatakis L; Carmen DJ; Awasthi S; Hwang J; Weil R; Merisaari H; Mohamed N; Deane LA; Chakravarty D; Yadav KK; Yamoah K; Nair SS; Tewari AK
Commun Biol; 2021 Jun; 4(1):670. PubMed ID: 34083737
[TBL] [Abstract][Full Text] [Related]
6. Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.
Howard LE; Zhang J; Fishbane N; Hoedt AM; Klaassen Z; Spratt DE; Vidal AC; Lin D; Hitchins MP; You S; Freeman MR; Yamoah K; Davicioni E; Freedland SJ
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):419-428. PubMed ID: 31844180
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities.
Ramirez-Torres A; Reagan AL; Howard LE; Wiggins E; Vidal AC; Wan J; Miller B; Freedland SJ; Cohen P
Prostate; 2022 Sep; 82(13):1248-1257. PubMed ID: 35789022
[TBL] [Abstract][Full Text] [Related]
8. Evidence for molecular differences in prostate cancer between African American and Caucasian men.
Khani F; Mosquera JM; Park K; Blattner M; O'Reilly C; MacDonald TY; Chen Z; Srivastava A; Tewari AK; Barbieri CE; Rubin MA; Robinson BD
Clin Cancer Res; 2014 Sep; 20(18):4925-34. PubMed ID: 25056375
[TBL] [Abstract][Full Text] [Related]
9. A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men.
Murphy AB; Carbunaru S; Nettey OS; Gornbein C; Dixon MA; Macias V; Sharifi R; Kittles RA; Yang X; Kajdacsy-Balla A; Gann P
Urology; 2020 Aug; 142():166-173. PubMed ID: 32277993
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
Cullen J; Lynch JA; Klein EA; Van Den Eeden SK; Carroll PR; Mohler JL; Knezevic D; Farrington TA; Lu R
J Urol; 2021 Apr; 205(4):1047-1054. PubMed ID: 33493001
[TBL] [Abstract][Full Text] [Related]
12. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
[TBL] [Abstract][Full Text] [Related]
13. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.
Yamoah K; Johnson MH; Choeurng V; Faisal FA; Yousefi K; Haddad Z; Ross AE; Alshalafa M; Den R; Lal P; Feldman M; Dicker AP; Klein EA; Davicioni E; Rebbeck TR; Schaeffer EM
J Clin Oncol; 2015 Sep; 33(25):2789-96. PubMed ID: 26195723
[TBL] [Abstract][Full Text] [Related]
14. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.
Powell IJ; Chinni SR; Reddy SS; Zaslavsky A; Gavande N
Urol Oncol; 2021 Jan; 39(1):34-40. PubMed ID: 32900629
[TBL] [Abstract][Full Text] [Related]
16. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men.
Powell IJ; Vigneau FD; Bock CH; Ruterbusch J; Heilbrun LK
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1505-11. PubMed ID: 24802741
[TBL] [Abstract][Full Text] [Related]
17. The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy.
Hart KB; Wood DP; Tekyi-Mensah S; Porter AT; Pontes JE; Forman JD
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1235-8. PubMed ID: 10613318
[TBL] [Abstract][Full Text] [Related]
18. Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.
Teslow EA; Bao B; Dyson G; Legendre C; Mitrea C; Sakr W; Carpten JD; Powell I; Bollig-Fischer A
Mol Oncol; 2018 Jun; 12(7):1138-1152. PubMed ID: 29741809
[TBL] [Abstract][Full Text] [Related]
19. Racial disparity of epidermal growth factor receptor expression in prostate cancer.
Shuch B; Mikhail M; Satagopan J; Lee P; Yee H; Chang C; Cordon-Cardo C; Taneja SS; Osman I
J Clin Oncol; 2004 Dec; 22(23):4725-9. PubMed ID: 15570072
[TBL] [Abstract][Full Text] [Related]
20. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males.
Iselin CE; Box JW; Vollmer RT; Layfield LJ; Robertson JE; Paulson DF
Cancer; 1998 Dec; 83(11):2353-60. PubMed ID: 9840535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
